サイト内検索

登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録

連絡先

TEL．03-5812-5270
FAX．03-3831-0495
E-mail：info@spi-information.com

関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

神経刺激デバイス‐世界のパイプライン分析、事業機会の評価と2016年までの市場予測

レポート概要

本レポートは、世界の神経刺激デバイス市場における重要な市場データ、分析、さらには同市場における市場展望、市場勢力図、および市場動向に関する情報を提供します。また、同市場に影響を及ぼす重要な動向についての包括的情報、市場力学における重要な分析的内容も含み、さらに、市場勢力図、主要パイプライン製品や技術提供についても補足します。

■調査範囲

  • アメリカ、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、日本、中国、インド、オーストラリア、ブラジルなどの重要な地域をカバーします。
  • 主な市場セグメントは、深部脳刺激装置、脊髄刺激装置、迷走神経刺激装置です。
  • 2002〜2009年までの年間市場収益と2016年までの7年間の予測、および2009年の企業別シェアデータを提供します。
  • 神経刺激デバイス市場内における重要な市場動向、市場促進および抑制因子を定性的に分析します。
  • 主要企業、市場勢力図、および主なパイプライン製品と技術についての情報を提供します。
  • 主要企業は、Medtronic社、St. Jude Medical社、Boston Scientific Corporation社、Cyberonics社です。
  • GlobalData社の業界専門家のチームによる独自のデータベース、一次的および二次的研究、および社内の分析から、データと情報を提供します。

レポート詳細

目次

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Introduction and Overview
2.1 GlobalData Report Guidance

3 Disease Overview
3.1 Disease Overview: Parkinson’s Disease
3.1.1 Introduction
3.1.2 Etiology
3.1.3 Signs and Symptoms
3.1.4 Pathophysiology
3.1.5 Treatment
3.1.6 Epidemiology
3.2 Disease Overview: Chronic Pain
3.2.1 Introduction
3.2.2 Etiology
3.2.3 Signs and Symptoms
3.2.4 Pathophysiology
3.2.5 Treatment
3.2.6 Epidemiology
3.3 Disease Overview: Epilepsy
3.3.1 Introduction
3.3.2 Etiology
3.3.3 Signs and Symptoms
3.3.4 Pathophysiology
3.3.5 Treatment
3.3.6 Epidemiology

4 Neurostimulation Device Based Treatment Overview
4.1 Neurostimulation Devices: Technology Overview
4.1.1 Introduction
4.1.2 Advantages and Disadvantages of Neurostimulation Therapy
4.1.3 Types of Neurostimulators

5 Global Neurostimulation Devices Market: Global Market Characterization
5.1 Global Neurostimulation Devices Market, Revenues($m), 2002 − 2009
5.2 Global Neurostimulation Devices Market, Revenues($m), 2009 − 2016
5.3 Neurostimulation Devices: Key Market Trends
5.4 Neurostimulation Devices: Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
5.5 Neurostimulation Devices: Key Opportunities and Unmet Needs
5.5.1 Opportunities
5.5.2 Unmet Need

6 Global Neurostimulation Devices Market: Segment Wise Analysis
6.1 Deep Brain Stimulation Devices Market: Market Characterization
6.1.1 Deep Brain Stimulation Devices Market, Revenues ($m), 2002 − 2009
6.1.2 Deep Brain Stimulation Devices Market, Revenues ($m), 2009 − 2016
6.2 Spinal Cord Stimulation Devices Market: Market Characterization
6.2.1 Spinal Cord Stimulation Devices Market, Revenues ($m), 2002 − 2009
6.2.2 Spinal Cord Stimulation Devices Market, Revenues ($m), 2009 − 2016
6.3 Vagus Nerve Stimulation Devices Market: Market Characterization
6.3.1 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2002 − 2009
6.3.2 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2009 − 2016

7 Global Neurostimulation Devices Market: Country Wise Market Analysis and Forecasts
7.1 Global Neurostimulation Devices Market: Cross-Country Market Analysis and Forecasts
7.1.1 Cross-Country Analysis of Neurostimulation Devices market, 2009
7.2 Revenues and Forecasts, By Country
7.2.1 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 –
7.2.2 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.3 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.4 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.5 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.6 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.7 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.8 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.9 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.10 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.11 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.12 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.13 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.14 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.15 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.16 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.17 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.18 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.19 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.20 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.21 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 − 2009
7.2.22 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016
7.2.23 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009
7.2.24 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016

8 Global Neurostimulation Devices Market: Competitive Assessment
8.1 Global Neurostimulation Devices Market, Key Company Shares (%), 2009
8.2 Medtronic, Inc
8.2.1 Overview
8.2.2 Neurostimulation Devices Portfolio
8.3 St. Jude Medical, Inc
8.3.1 Overview
8.3.2 Neurostimulation Devices Portfolio
8.4 Boston Scientific Corporation
8.4.1 Overview
8.4.2 Neurostimulation Devices Portfolio
8.5 Cyberonics, Inc
8.5.1 Overview
8.5.2 Neurostimulation Devices Portfolio

9 Global Neurostimulation Devices Market: Key Marketed Products
9.1 Medtronic, Inc: Activa RC
9.1.1 Product Description
9.1.2 Features and Benefits
9.2 Medtronic, Inc: RestoreUltra
9.2.1 Product Description
9.2.2 Features and Benefits
9.3 St. Jude’s Medical, Inc: Eon Mini
9.3.1 Product Description
9.3.2 Features and Benefits
9.4 Boston Scientific Corporation: Precision Plus
9.4.1 Product Description
9.4.2 Features and Benefits
9.5 Cyberonics, Inc: VNS Therapy
9.5.1 Product Description
9.5.2 Features and Benefits

10 Global Neurostimulation Devices Market: Strategic Pipeline Assessment
10.1 Neurostimulation Devices: List of Pipeline Products
10.2 Pipeline Products Assessment for Neurostimulation Devices by Segment, Global, 2010
10.3 Neurostimulation Devices: Profiles of Pipeline Products Under Clinical Development
10.3.1 Cyberonics, Inc: 3T MRI Safe Lead
10.3.2 Boston Scientific Corporation: Bion Microstimulator System for chronic headache
10.3.3 Brainsway, Inc: Deep TMS H System
10.3.4 Intelect Medical, Inc: Enspire DBS Therapy System for Stroke
10.3.5 Magstim Company Limited: Magstim eldith DC Stimulator plus
10.3.6 DynaMed Systems, LLC: Traxon

11 Global Neurostimulation Devices Market: M&A Landscape
11.1 Global Neurostimulation Devices Market: Deals Overview
11.2 Global Neurostimulation Devices Market: Key Acquisitions
11.2.1 St. Jude Medical Acquires Northstar Neuroscience
11.2.2 Greatbatch Acquires Quan Emerteq
11.2.3 Greatbatch Acquires Enpath Medical

12 Appendix
12.1 Definitions
12.2 Acronyms
12.3 Information Sources
12.4 Research Methodology
12.5 Secondary Research
12.6 Primary Research
12.7 Models
12.8 Forecasts
12.9 Expert Panels
12.10 GlobalData Consulting
12.11 Contact Us
12.12 Disclaimer

List of Figures
Figure 1: Neurostimulation Therapy, FDA Year of Approval
Figure 2: Neurostimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Figure 3: Neurostimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Figure 4: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010
Figure 5: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Figure 6: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Figure 7: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Figure 8: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Figure 9: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Figure 10: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 20016
Figure 11: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 − 2016
Figure 12: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009
Figure 13: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016
Figure 14: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009
Figure 15: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016
Figure 16: Neurostimulation Devices Market, UK Revenues ($m), By Segment, 2002 – 2009
Figure 17: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016
Figure 18: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009
Figure 19: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016
Figure 20: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009
Figure 21: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016
Figure 22 Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009
Figure 23: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016
Figure 24: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009
Figure 25: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016
Figure 26: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009
Figure 27: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016
Figure 28: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009
Figure 29: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016
Figure 30: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009
Figure 31: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016
Figure 32: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 − 2009
Figure 33: Neurostimulation Devices Market, Australia. Revenues ($m), By Segment, 2009 – 2016
Figure 34: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 − 2016
Figure 35: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016
Figure 36: : Neurostimulation Devices Market, Global, Key Company Shares (%), 2009
Figure 37: Pipeline Product Assessment for Neurostimulation Devices by Segment, Global
Figure 38: Neurostimulation Devices Market, Global, Deals Overview, 2005 − 2009
Figure 39: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 − 2009
Figure 40: GlobalData Methodology

List of Tables
Table 1: Neurostimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Table 2: Neurostimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Table 3: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Table 4: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Table 5: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Table 6: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Table 7: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 − 2009
Table 8: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2009 − 2016
Table 9: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 − 2016
Table 10: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009
Table 11: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016
Table 12: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009
Table 13: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016
Table 14: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2002 – 2009
Table 15: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016
Table 16: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009
Table 17: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016
Table 18: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009
Table 19: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016
Table 20: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009
Table 21: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016
Table 22: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009
Table 23: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016
Table 24: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009
Table 25: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016
Table 26: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009
Table 27: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016
Table 28: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009
Table 29: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016
Table 30: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 − 2009
Table 31: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2009 – 2016
Table 32: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 – 2009
Table 33: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016
Table 34: Neurostimulation Devices Market, Global, Key Company Shares ($m), 2009
Table 35: Medtronic, Inc., Key Marketed Products, Neurostimulation Devices Category
Table 36: St. Jude Medical, Inc. Key Marketed Products, Neurostimulation Devices Category
Table 37: Boston Scientific Corp., Key Marketed Products, Neurostimulation Devices Category
Table 38: Cyberonics, Inc , Key Marketed Products, Neurostimulation Devices Category
Table 39: Activa RC Deep Brain Neurostimulator, Features and Benefits
Table 40: RestoreUltra Spinal Cord Neurostimulator, Features and Benefits
Table 41: Eon Mini Spinal Cord Stimulator, Features and Benefits
Table 42: Precision Plus Spinal Cord Stimulator, Features and Benefits
Table 43: VNS Therapy Features and Benefits
Table 44: Neurostimulation Devices, Pipeline Products, 2010, Table
Table 45: Neurostimulation Devices, Pipeline Products, 2010, Table
Table 46: Neurostimulation Devices, Pipeline Products, 2010, Table
Table 47: Neurostimulation Devices Market, Global, Deals Overview, 2005 − 2009
Table 48: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 − 2009
Table 49: Neurostimulation Devices Industry, Global, List of M&A Deals, 2004 − 2010

発刊日

2010/08/12

体裁

PDF / 76ページ

販売価格

3,500USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる

PAGE